NorthStar awarded $37 million for Mo-99 production

August 30, 2021, 7:01AMNuclear News
NorthStar’s RadioGenix system produces the medical radioisope Mo-99 without the use of uranium. (Photo: NorthStar)

NorthStar Medical Technologies of Beloit, Wis., will receive $37 million under two cooperative agreements with the National Nuclear Security Administration for the production of molybdenum-99 without the use of high-enriched uranium. Considered a critical medical radioisotope, Mo-99 is used in more than 40,000 medical procedures in the United States each day, including the diagnosis of heart disease and cancer.

To continue reading, log in or create a free account!

Related Articles

NNSA’s CIRP checks Kansas off its list

September 12, 2025, 6:56AMNuclear News

Kansas in now one of 11 U.S. states and territories that is free of cesium-137 irradiators—the others being Alaska, Arizona, Delaware, Idaho, Iowa, Nevada, New Mexico, Puerto Rico, South...